Benefit of TIPS for patients with refractory or recidivant ascites: Serum bilirubin may make the difference [2]

Hepatology

Volumn 41, Issue 1, 2005, Pages 217-

  Gerbes, Alexander L ^a   Gülberg, Veit ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ASCITES; BILIRUBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LETTER; LIVER CIRRHOSIS; PARACENTESIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL;

ASCITES; BILIRUBIN; HUMANS; LIVER CIRRHOSIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 11244339731     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20509     Document Type: Letter

References (8)

1. Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al. Randomized conrolled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. HEPATOLOGY 2004;40:629-635.
2. Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-1707.
3. Sanyal AJ, Genning C, Rajender Reddy K, Wong F, Kowdley KV, Benner K, et al. The North American study for the treatment of refractory ascites. Gastroenterology 2003124:634-641.
4. Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Ruiz Del Arbol L, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-1847.
5. Gülberg V, Liss I, Bilzer M, Waggershauser T, Reiser M, Gerbes AL. Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts. Digestion 2002;66:127-130.
6. Nazarian GK, Ferral H, Bjarnason H, Castaneda-Zuniga WR, Rank JM, Bernadas CA, et al. Effect of transjugular intrahepatic portosystemic shunt on quality of life. AJR Am J Roentgenol 1996;167:963-969.
7. Zhuang ZW, Teng GJ, Jeffery RF, Gemery JM, D'Othee BJ, Bettmann MA. Long-term results and quality of life in patients treated with transjugular intrahepatic portosystemic shunts. AJR Am J Roentgenol 2002;179:1597-1603.
8. Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol 2002;13:155-161.